Home | Business News | Browse by Publication | P | PR Newswire

FDA Approves New Therapy for Secondary Hyperparathyroidism, a Major Complication Associated With Chronic Kidney Disease.

Publication: PR Newswire
Publication Date: 27-MAY-05
Format: Online
Delivery: Immediate Online Access

Article Excerpt
More Than 20 Million Americans Are At Risk

NEW YORK, May 27 /PRNewswire/ -- ADDITIONAL RESOURCES: Video, hard copy requests, contact information and more available at http://www.prnewswire.com/broadcast/21750/consumer.shtml

STORY SUMMARY:

According to the National Kidney Foundation, more than 20 million Americans -- that's one in nine adults -- have chronic...

View this article FREE - Now for a Limited Time, try Goliath Business News
Free for 3 Days!



More articles from PR Newswire
United Industrial Corporation Elects Directors at Annual Meeting., May 27, 2005
Refco Group Ltd., LLC Reports Fourth Quarter and Year-End Results., May 27, 2005
Delacorte Press Books for Young Readers Announces Winner of the 'Win a..., May 27, 2005
Regent Communications to Present at the Friedman Billings Ramsey Annua..., May 27, 2005
Florida Governor Jeb Bush Signs Into Law Landmark International Insura..., May 27, 2005

Looking for additional articles?
Search our database of over 3 million articles.

Looking for more in-depth information on this industry?
Search our complete database of Industry & Market reports by text, subject, publication name or publication date.

About Goliath
Whether you're looking for sales prospects, competitive information, company analysis or best practices in managing your organization, Goliath can help you meet your business needs.

Our extensive business information databases empower business professionals with both the breadth and depth of credible, authoritative information they need to support their business goals. Whether it be strategic planning, sales prospecting, company research or defining management best practices - Goliath is your leading source for accurate information.